A Pain-Drug Champion Has Second Thoughts – WSJ.com

Published December 15, 2012

A Pain-Drug Champion Has Second Thoughts – WSJ.com

Filed under: drug rehab treatment programs

In 2007, Purdue Pharma and three executives pleaded guilty to "misbranding" of the drug as less addictive and less subject to abuse than other pain medicines and paid $ 635 million in fines. Purdue Pharma says it has worked to … In 1998, the …
Read more on Wall Street Journal

FDA Gives Early Approval to Drug for Rare Leukemia

Filed under: drug rehab treatment programs

Now there is the grandson of Gleevec. The Food and Drug Administration on Friday approved another Gleevec-like drug for the treatment of chronic myeloid leukemia, or C.M.L., adding to a crowded field vying to treat this rare cancer of white blood cells.
Read more on New York Times

FDA approves Signifor, a new orphan drug for Cushing's disease

Filed under: drug rehab treatment programs

The U.S. Food and Drug Administration today approved Signifor (pasireotide diaspartate) injection for the treatment of Cushing's disease patients who cannot be helped through surgery. Cushing's disease is caused by over-production of cortisol, a …
Read more on FDA.gov